Searchable abstracts of presentations at key conferences in endocrinology

ea0011p136 | Clinical case reports | ECE2006

Epilepsy at presentation of macroprolactinoma

Deepak D , Bashir N , Foy P , Macfarlane IA

Objectives: Prolactinomas can extend out of the sella turcica and invade surrounding structures and the brain. The prevalence and natural history of epilepsy at presentation of macroprolactinoma is not clear.Methods: The case records of 62 patients (34 male) with macroprolactinoma attending a neuroendocrine clinic were studied.Results: Four patients (6.5%, 3 males) had experienced epileptic seizures before the diagnosis of macropro...

ea0005p150 | Endocrine Tumours and Neoplasia | BES2003

Expression of vascular endothelial growth factor and its receptors in human anterior pituitary adenomas

Adams I , Henderson R , Green V , Foy P , Macfarlane I , Atkin S

Vascular Endothelial Growth Factor (VEGF) is an important growth factor, simulating the process of angiogenesis which is required for tumour progression. It mainly acts through 2 receptors VEGF-R1 and VEGF-R2. Whilst the presence of VEGF has been shown in pituitary adenomas, no study has undertaken the quantification of the expression of VEGF121, VEGF165, VEGF-R1 and VEGF-R2, and whether their expression may correlate.METHODS. We have used the technique of quantitative RT-...

ea0005p152 | Endocrine Tumours and Neoplasia | BES2003

Can petrosal sinus ACTH and prolactin responses to CRH help localize the tumour in Cushing's disease due to pituitary microadenomas?

Daousi C , Nixon T , Hayden C , Foy P , Diver M , MacFarlane I

Aims: The majority of patients with Cushing's disease have pituitary microadenomas and preoperative localization can be helpful during transphenoidal surgery. Inferior petrosal sinus sampling (IPSS) of ACTH and responses to CRH may show higher levels on the side ipsilateral to the tumour, although this remains controversial. A few small studies suggested a prolactin response to CRH during IPSS. We assessed whether prolactin responses to CRH can help lateralize the microadenoma...

ea0002p60 | Neuroendocrinology | SFE2001

Elderly people with hypothalamic-pituitary disease and untreated growth hormone deficiency: Clinical outcome, body composition, lipid profiles and quality of life after 2 years compared to controls

Li|#Voon|#Chong J , Groves T , Foy P , Wallymahmed M , MacFarlane I

OBJECTIVE: To assess the impact of untreated growth hormone deficiency (GHD) over 2 yrs in elderly patients with hypothalamic-pituitary disease. Controls were also followed for 2 yrs.SUBJECTS: 27 patients (>65 yrs) with GHD (mean) peak stimulated GH 1.6 mIU/l(range 0.6-5)were initially studied. Two yrs later 21(13 males) agreed to attend for reassessment. 27 controls (>65 y) were studied at baseline and 17 (7 males) agreed to attend for reassessmen...